Pathria G - Search Results

1

NRF2 mediates melanoma addiction to GCDH by modulating apoptotic signalling.

Verma S, Crawford D, Khateb A, Feng Y, Sergienko E, Pathria G, Ma CT, Olson SH, Scott D, Murad R, Ruppin E, Jackson M, Ronai ZA. Verma S, et al. Among authors: pathria g. Nat Cell Biol. 2022 Sep;24(9):1422-1432. doi: 10.1038/s41556-022-00985-x. Epub 2022 Sep 1. Nat Cell Biol. 2022. PMID: 36050469 Free PMC article.

2

BRN 2 Invade.

Pathria G, Ronai ZA. Pathria G, et al. Cancer Cell. 2018 Jul 9;34(1):1-3. doi: 10.1016/j.ccell.2018.06.010. Cancer Cell. 2018. PMID: 29990495 Free PMC article.

3

Targeting the Warburg effect via LDHA inhibition engages ATF4 signaling for cancer cell survival.

Pathria G, Scott DA, Feng Y, Sang Lee J, Fujita Y, Zhang G, Sahu AD, Ruppin E, Herlyn M, Osterman AL, Ronai ZA. Pathria G, et al. EMBO J. 2018 Oct 15;37(20):e99735. doi: 10.15252/embj.201899735. Epub 2018 Sep 12. EMBO J. 2018. PMID: 30209241 Free PMC article.

4

Translational reprogramming marks adaptation to asparagine restriction in cancer.

Pathria G, Lee JS, Hasnis E, Tandoc K, Scott DA, Verma S, Feng Y, Larue L, Sahu AD, Topisirovic I, Ruppin E, Ronai ZA. Pathria G, et al. Nat Cell Biol. 2019 Dec;21(12):1590-1603. doi: 10.1038/s41556-019-0415-1. Epub 2019 Nov 18. Nat Cell Biol. 2019. PMID: 31740775 Free PMC article.

5

Harnessing the Co-vulnerabilities of Amino Acid-Restricted Cancers.

Pathria G, Ronai ZA. Pathria G, et al. Cell Metab. 2021 Jan 5;33(1):9-20. doi: 10.1016/j.cmet.2020.12.009. Cell Metab. 2021. PMID: 33406406 Free PMC article. Review.

6

MAPK signaling regulates c-MYC for melanoma cell adaptation to asparagine restriction.

Pathria G, Verma S, Yin J, Scott DA, Ronai ZA. Pathria G, et al. EMBO Rep. 2021 Mar 3;22(3):e51436. doi: 10.15252/embr.202051436. Epub 2021 Feb 8. EMBO Rep. 2021. PMID: 33554439 Free PMC article.

7

Identification and Characterization of IMD-0354 as a Glutamine Carrier Protein Inhibitor in Melanoma.

Feng Y, Pathria G, Heynen-Genel S, Jackson M, James B, Yin J, Scott DA, Ronai ZA. Feng Y, et al. Among authors: pathria g. Mol Cancer Ther. 2021 May;20(5):816-832. doi: 10.1158/1535-7163.MCT-20-0354. Epub 2021 Feb 25. Mol Cancer Ther. 2021. PMID: 33632871 Free PMC article.

8

Dual suppression of the cyclin-dependent kinase inhibitors CDKN2C and CDKN1A in human melanoma.

Jalili A, Wagner C, Pashenkov M, Pathria G, Mertz KD, Widlund HR, Lupien M, Brunet JP, Golub TR, Stingl G, Fisher DE, Ramaswamy S, Wagner SN. Jalili A, et al. Among authors: pathria g. J Natl Cancer Inst. 2012 Nov 7;104(21):1673-9. doi: 10.1093/jnci/djs373. Epub 2012 Sep 20. J Natl Cancer Inst. 2012. PMID: 22997239 Free PMC article.

9

RanBP3 Regulates Melanoma Cell Proliferation via Selective Control of Nuclear Export.

Pathria G, Garg B, Wagner C, Garg K, Gschaider M, Jalili A, Wagner SN. Pathria G, et al. J Invest Dermatol. 2016 Jan;136(1):264-74. doi: 10.1038/JID.2015.401. J Invest Dermatol. 2016. PMID: 26763446 Free article.

10

Overcoming MITF-conferred drug resistance through dual AURKA/MAPK targeting in human melanoma cells.

Pathria G, Garg B, Borgdorff V, Garg K, Wagner C, Superti-Furga G, Wagner SN. Pathria G, et al. Cell Death Dis. 2016 Mar 10;7(3):e2135. doi: 10.1038/cddis.2015.369. Cell Death Dis. 2016. PMID: 26962685 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters